SwissBioisostere 2021: updated structural, bioactivity and physicochemical data delivered by a reshaped web interface

Nucleic Acids Res. 2022 Jan 7;50(D1):D1382-D1390. doi: 10.1093/nar/gkab1047.

ABSTRACT

At several stages of drug discovery, bioisosteric replacement is a common and efficient practice to find new bioactive chemotypes or to optimize series of molecules toward drug candidates. The critical steps consisting in selecting which molecular moiety should be replaced by which other chemical fragment is often relying on the expertise of specialists. Nowadays, valuable support can be obtained through the wealth of dedicated structural and knowledge data. The present article details the update of SwissBioisostere, a database of >25 millions of unique molecular replacements with data on bioactivity, physicochemistry, chemical and biological contexts extracted from the literature and related resources. The content of the database together with analysis and visualization capacities is freely available at www.swissbioisostere.ch.

PMID:34788840 | PMC:PMC8728117 | DOI:10.1093/nar/gkab1047